Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Renal cell carcinoma with MiTF/TFE3 translocation in children: report of a case at the stage of lymph node involvement.

Fall B, Sarr A, Sow Y, Diao B.

Afr J Paediatr Surg. 2011 Sep-Dec;8(3):317-9. doi: 10.4103/0189-6725.91669.

2.

[Research advances in Xp11.2 translocation renal cell carcinoma].

Huang JH, Zhou FJ.

Ai Zheng. 2008 Sep;27(9):1006-8. Review. Chinese.

PMID:
18799045
3.

Translocation renal cell carcinoma: lack of negative impact due to lymph node spread.

Geller JI, Argani P, Adeniran A, Hampton E, De Marzo A, Hicks J, Collins MH.

Cancer. 2008 Apr 1;112(7):1607-16. doi: 10.1002/cncr.23331.

4.

Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.

Komai Y, Fujiwara M, Fujii Y, Mukai H, Yonese J, Kawakami S, Yamamoto S, Migita T, Ishikawa Y, Kurata M, Nakamura T, Fukui I.

Clin Cancer Res. 2009 Feb 15;15(4):1170-6. doi: 10.1158/1078-0432.CCR-08-1183.

5.

Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.

Argani P, Olgac S, Tickoo SK, Goldfischer M, Moch H, Chan DY, Eble JN, Bonsib SM, Jimeno M, Lloreta J, Billis A, Hicks J, De Marzo AM, Reuter VE, Ladanyi M.

Am J Surg Pathol. 2007 Aug;31(8):1149-60.

PMID:
17667536
6.

Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome.

Mir MC, Trilla E, de Torres IM, Panizo A, Zlotta AR, Van Rhijn B, Morote J.

BJU Int. 2011 Jul;108(2 Pt 2):E71-6. doi: 10.1111/j.1464-410X.2010.09818.x. Epub 2010 Nov 10.

7.

Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.

Klatte T, Streubel B, Wrba F, Remzi M, Krammer B, de Martino M, Waldert M, Marberger M, Susani M, Haitel A.

Am J Clin Pathol. 2012 May;137(5):761-8. doi: 10.1309/AJCPQ6LLFMC4OXGC.

8.

Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.

Altinok G, Kattar MM, Mohamed A, Poulik J, Grignon D, Rabah R.

Pediatr Dev Pathol. 2005 Mar-Apr;8(2):168-80. Epub 2005 Mar 8.

PMID:
15747097
9.

Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.

Winarti NW, Argani P, De Marzo AM, Hicks J, Mulyadi K.

Int J Surg Pathol. 2008 Jan;16(1):66-72. doi: 10.1177/1066896907304994.

PMID:
18203790
10.

[Renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with lymph node metastasis diagnosed after an injury accident: report of a case].

Chen Y, Kang S, Qiu J.

Zhonghua Bing Li Xue Za Zhi. 2014 Feb;43(2):123-4. Chinese. No abstract available.

PMID:
24742576
11.

XP11.2 translocation renal cell carcinoma: clinical experience of Taipei Veterans General Hospital.

Hung CC, Pan CC, Lin CC, Lin AT, Chen KK, Chang YH.

J Chin Med Assoc. 2011 Nov;74(11):500-4. doi: 10.1016/j.jcma.2011.09.005. Epub 2011 Nov 1.

12.

Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features.

Suzigan S, Drut R, Faria P, Argani P, De Marzo AM, Barbosa RN, Mello Denadai ER, Martins-Filho J, Martucci RC, Bauab T Jr.

Int J Surg Pathol. 2007 Apr;15(2):199-203.

PMID:
17478783
13.

A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma.

Kurisaki-Arakawa A, Saito T, Takahashi M, Mitani K, Fukumura Y, Nagashima Y, Argani P, Yao T.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2585-90. eCollection 2013.

14.

Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers.

Argani P, Hicks J, De Marzo AM, Albadine R, Illei PB, Ladanyi M, Reuter VE, Netto GJ.

Am J Surg Pathol. 2010 Sep;34(9):1295-303. doi: 10.1097/PAS.0b013e3181e8ce5b.

15.

A case of PSF-TFE3 gene fusion in Xp11.2 renal cell carcinoma with melanotic features.

Zhan HQ, Chen H, Wang CF, Zhu XZ.

Hum Pathol. 2015 Mar;46(3):476-81. doi: 10.1016/j.humpath.2014.11.013. Epub 2014 Dec 9.

PMID:
25582502
16.

Molecular heterogeneity of TFE3 activation in renal cell carcinomas.

Macher-Goeppinger S, Roth W, Wagener N, Hohenfellner M, Penzel R, Haferkamp A, Schirmacher P, Aulmann S.

Mod Pathol. 2012 Feb;25(2):308-15. doi: 10.1038/modpathol.2011.169. Epub 2011 Oct 28.

17.

Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation.

Barroca H, Castedo S, Vieira J, Teixeira M, Müller-Höcker J.

Pathol Res Pract. 2009;205(7):466-72. doi: 10.1016/j.prp.2009.01.005. Epub 2009 Feb 25.

PMID:
19246164
18.

PRCC-TFE3 renal cell carcinoma in a boy with a history of contralateral mesoblastic nephroma.

Onder AM, Teomete U, Argani P, Toledano S, Zilleruelo G, Rodriguez MM.

Pediatr Nephrol. 2006 Oct;21(10):1471-5. Epub 2006 Jun 29.

PMID:
16807766
19.

Kidney carcinoma associated with Xp11.2 translocation / TFE3 (ASPL-TFE3) gene fusion.

Salles PG, Soto M Jr.

Int Braz J Urol. 2005 May-Jun;31(3):251-4.

20.

Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect.

Kuroda N, Mikami S, Pan CC, Cohen RJ, Hes O, Michal M, Nagashima Y, Tanaka Y, Inoue K, Shuin T, Lee GH.

Histol Histopathol. 2012 Feb;27(2):133-40. Review.

PMID:
22207547
Items per page

Supplemental Content

Write to the Help Desk